Mathematical modeling of the in vitro hepatic disposition of mycophenolic acid and its glucuronide in sandwich-cultured human hepatocytes.
暂无分享,去创建一个
T. Nakanishi | I. Tamai | M. Ogawa | S. Wada | M. Ikenaga | N. Matsunaga
[1] K. Brouwer,et al. In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development , 2013, Clinical pharmacology and therapeutics.
[2] P. Annaert,et al. Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity , 2013, Expert opinion on drug metabolism & toxicology.
[3] I. Tamai,et al. Evaluation of Hepatic Disposition of Paroxetine Using Sandwich-Cultured Rat and Human Hepatocytes , 2013, Drug Metabolism and Disposition.
[4] F. Akhlaghi,et al. Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus , 2013, Xenobiotica; the fate of foreign compounds in biological systems.
[5] T. Nakanishi,et al. Application of quantitative time-lapse imaging (QTLI) for evaluation of Mrp2-based drug-drug interaction induced by liver metabolites. , 2012, Toxicology and applied pharmacology.
[6] Hugh A. Barton,et al. Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data , 2012, Drug Metabolism and Disposition.
[7] Yongling Xiao,et al. Differential Modulation of Cytochrome P450 Activity and the Effect of 1-Aminobenzotriazole on Hepatic Transport in Sandwich-Cultured Human Hepatocytes , 2012, Drug Metabolism and Disposition.
[8] G. Keating,et al. Enteric-Coated Mycophenolate Sodium , 2012, Drugs.
[9] T. Horie,et al. Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes. , 2011, Biochemical and biophysical research communications.
[10] K. Maeda,et al. Culture Period-Dependent Changes in the Uptake of Transporter Substrates in Sandwich-Cultured Rat and Human Hepatocytes , 2011, Drug Metabolism and Disposition.
[11] J. Sahi,et al. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[12] T. Nakanishi,et al. Quantitative Time-Lapse Imaging-Based Analysis of Drug-Drug Interaction Mediated by Hepatobiliary Transporter, Multidrug Resistance-Associated Protein 2, in Sandwich-Cultured Rat Hepatocytes , 2011, Drug Metabolism and Disposition.
[13] A. Prémaud,et al. Large Scale Analysis of Routine Dose Adjustments of Mycophenolate Mofetil Based on Global Exposure in Renal Transplant Patients , 2011, Therapeutic drug monitoring.
[14] D. B. Duignan,et al. Characterization of Digoxin Uptake in Sandwich-Cultured Human Hepatocytes , 2011, Drug Metabolism and Disposition.
[15] S. O. Mueller,et al. Development of an in vitro liver toxicity prediction model based on longer term primary rat hepatocyte culture. , 2008, Toxicology letters.
[16] M. Fromm,et al. SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients. , 2010, Pharmacogenomics.
[17] L. Melvin,et al. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes. , 2010, Canadian journal of physiology and pharmacology.
[18] Y. Lai,et al. Improved extrapolation of hepatobiliary clearance from in vitro sandwich cultured rat hepatocytes through absolute quantification of hepatobiliary transporters. , 2010, Molecular pharmaceutics.
[19] K. Brouwer,et al. Influence of seeding density and extracellular matrix on bile Acid transport and mrp4 expression in sandwich-cultured mouse hepatocytes. , 2010, Molecular pharmaceutics.
[20] C. Staatz,et al. Pharmacogenetic influences on mycophenolate therapy. , 2010, Pharmacogenomics.
[21] K. Brouwer,et al. Hepatobiliary Disposition of Troglitazone and Metabolites in Rat and Human Sandwich-Cultured Hepatocytes: Use of Monte Carlo Simulations to Assess the Impact of Changes in Biliary Excretion on Troglitazone Sulfate Accumulation , 2010, Journal of Pharmacology and Experimental Therapeutics.
[22] K. Giacomini,et al. The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics , 2010, Clinical pharmacology and therapeutics.
[23] Jennifer Q. Dong,et al. Glucuronidation and Covalent Protein Binding of Benoxaprofen and Flunoxaprofen in Sandwich-Cultured Rat and Human Hepatocytes , 2009, Drug Metabolism and Disposition.
[24] M. Niemi,et al. Impact of OATP transporters on pharmacokinetics , 2009, British journal of pharmacology.
[25] S. O. Mueller,et al. Serum-free collagen sandwich cultures of adult rat hepatocytes maintain liver-like properties long term: a valuable model for in vitro toxicity and drug-drug interaction studies. , 2009, Chemico-biological interactions.
[26] Y. Kagawa,et al. Impact of Calcineurin Inhibitors on Urinary Excretion of Mycophenolic Acid and Its Glucuronide in Kidney Transplant Recipients , 2009, Journal of clinical pharmacology.
[27] Shufeng Zhou,et al. Mechanism‐Based Enterohepatic Circulation Model of Mycophenolic Acid and Its Glucuronide Metabolite: Assessment of Impact of Cyclosporine Dose in Asian Renal Transplant Patients , 2009, Journal of clinical pharmacology.
[28] Y. Sugiyama,et al. Functional analysis of nonsynonymous single nucleotide polymorphism type ATP-binding cassette transmembrane transporter subfamily C member 3 , 2008, Pharmacogenetics and genomics.
[29] Rikiya Ohashi,et al. Effect of Plasma Protein Binding on in Vitro-in Vivo Correlation of Biliary Excretion of Drugs Evaluated by Sandwich-Cultured Rat Hepatocytes , 2008, Drug Metabolism and Disposition.
[30] C. Guillemette,et al. The Impact of UGT1A8, UGT1A9, and UGT2B7 Genetic Polymorphisms on the Pharmacokinetic Profile of Mycophenolic Acid After a Single Oral Dose in Healthy Volunteers , 2007, Clinical pharmacology and therapeutics.
[31] C. Staatz,et al. Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant Recipients , 2007, Clinical pharmacokinetics.
[32] D. Keppler,et al. Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system , 2006, Neuroscience.
[33] V. Armstrong,et al. Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: Implications for drug exposure in renal allograft recipients , 2006, Clinical pharmacology and therapeutics.
[34] J. D. de Fijter,et al. Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling. , 2005, British journal of clinical pharmacology.
[35] Hanneke van Helvoort,et al. THE USE OF SANDWICH-CULTURED RAT HEPATOCYTES TO DETERMINE THE INTRINSIC CLEARANCE OF COMPOUNDS WITH DIFFERENT EXTRACTION RATIOS: 7-ETHOXYCOUMARIN AND WARFARIN , 2005, Drug Metabolism and Disposition.
[36] K. Brouwer,et al. P-glycoprotein Expression, Localization, and Function in Sandwich-Cultured Primary Rat and Human Hepatocytes: Relevance to the Hepatobiliary Disposition of a Model Opioid Peptide , 2004, Pharmaceutical Research.
[37] T. Hirano,et al. Cyclosporin A, but Not Tacrolimus, Inhibits the Biliary Excretion of Mycophenolic Acid Glucuronide Possibly Mediated by Multidrug Resistance-Associated Protein 2 in Rats , 2004, Journal of Pharmacology and Experimental Therapeutics.
[38] M. Fromm,et al. Influence of Omeprazole on Multidrug Resistance Protein 3 Expression in Human Liver , 2003, Journal of Pharmacology and Experimental Therapeutics.
[39] Yau Yi Lau,et al. Development of a novel in vitro model to predict hepatic clearance using fresh, cryopreserved, and sandwich-cultured hepatocytes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[40] N. Perico,et al. Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients , 2001, Clinical transplantation.
[41] J. Miners,et al. The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes. , 2001, British journal of clinical pharmacology.
[42] R. Tukey,et al. Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes , 2001, British journal of pharmacology.
[43] V. Armstrong,et al. Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. , 1999, Clinical chemistry.
[44] V. Armstrong,et al. Identification of glucoside and carboxyl‐linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil , 1999, British journal of pharmacology.
[45] W. Weimar,et al. Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[46] A. Nicholls,et al. Clinical Pharmacokinetics of Mycophenolate Mofetil , 1998, Clinical pharmacokinetics.
[47] R. Pichlmayr,et al. Drug metabolism in hepatocyte sandwich cultures of rats and humans. , 1997, Biochemical pharmacology.
[48] M. Hale,et al. Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous Administration , 1996, Journal of clinical pharmacology.
[49] K. Pang,et al. Effect of diffusional barriers on drug and metabolite kinetics. , 1987, Drug metabolism and disposition: the biological fate of chemicals.
[50] W. Cherry,et al. Disposition of enalapril and its diacid metabolite, enalaprilat, in a perfused rat liver preparation. Presence of a diffusional barrier for enalaprilat into hepatocytes. , 1984, Drug metabolism and disposition: the biological fate of chemicals.